Status:
COMPLETED
Associated Disorders of Locomotion and Postural Control of Axial Segments in Cerebral Palsy
Lead Sponsor:
Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est
Conditions:
Cerebral Palsy, Spastic
Eligibility:
All Genders
5-12 years
Phase:
NA
Brief Summary
Gait abnormalities, which occur in Cerebral Palsy (CP), are characterized usually by a toe-to-floor or a plantar-to-floor initial contact (equinus gait), followed by an early braking of the tibia's fo...
Eligibility Criteria
Inclusion
- Gross Motor Function Classification System I or II
- no or minimal contracture of the triceps surae
- presence of soleus spasticity
Exclusion
- botulinum toxin injections or surgery in the lower limb respectively in the 6 and 12 months preceding the study
- any modification of the physical or orthopaedic therapy within the last two months
- minimal hip flexion above 20° in a clinical examination
- pain in the lower legs when standing or walking
Key Trial Info
Start Date :
December 20 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2019
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT04287673
Start Date
December 20 2016
End Date
November 30 2019
Last Update
July 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Régional de Médecine Physique et de Réadaptation
Nancy, France, 54000